NANOG and glioblastoma: Consistent with our observations by immunostaining, OCT4 and NANOG showed a significant upregulation and HLA-ABC significant downregulation in ic-GSCs (FDR corrected p <0.001) compared to the parental GBM-DCs (Supplementary Figure S2A,C).